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AbsTrACT
In April 2017, the American Association for the 
Surgery of Trauma (AAST) asked the AAST Patient 
Assessment Committee to undertake a gap analysis 
for published clinical practice guidelines in emergency 
general surgery (EGS). Committee members 
performed literature searches to catalogue published 
guidelines for common EGS diseases and also to 
identify gaps in the literature where guidelines 
could be created. For five of the most common EGS 
conditions, acute appendicitis, acute cholecystitis, 
acute diverticulitis, acute pancreatitis, and small 
bowel obstruction, we found multiple well-referenced 
guidelines published by leading professional 
organizations. We have summarized guideline 
recommendations for each of these disease states 
stratified by the AAST EGS anatomic severity score 
based on these published consensus guidelines. These 
summaries could be used to help inform evidence-
based clinical decision-making, but are intended 
to be flexible and updatable in real time as further 
research emerges. Comprehensive guidelines were 
available for all of the diseases queried and identified 
gaps most commonly represented areas lacking a 
solid evidence base. These are therefore areas where 
further research is needed.
ACuTe AppendiCiTis mAnAgemenT 
guidelines summAry
Multiple societies have published guidelines for 
the diagnosis and management of appendicitis. 
Notably, a consensus statement was published 
in Surgical Endoscopy in 2015, and a summary 
from the World Society of Emergency Surgery 
was published in the World Journal of Emergency 
Surgery in 2016. Several other comprehensive 
guidelines covering imaging recommendations, 
antimicrobial prophylaxis and duration, laparo-
scopic versus open surgical approach, and optimal 
management of perforated appendicitis have been 
published. This review summarizes and references 
evidence-based guidelines for appendicitis by 
stage, as a reference guide for surgeons practicing 
emergency general surgery.
American 
Association 
for the 
surgery 
of Trauma 
grade description management references
I Acutely inflamed 
appendix, intact
Laparoscopic 
appendectomy
Non-operative 
therapy with 
antibiotics 
may be a 
reasonable 
alternative
No 
postoperative 
antibiotics 
are indicated 
in surgically 
managed 
appendicitis
1 2 3 4 6 7
3
2
II Gangrenous 
appendix, intact
Laparoscopic 
appendectomy
1 2 3 4 6 7
III Perforated 
appendix 
with local 
contamination
Laparoscopic 
appendectomy
1 2 3 4 6 7
IV Perforated 
appendix with 
periappendiceal 
phlegmon or 
abscess
Laparoscopic 
appendectomy
Non-operative 
therapy with 
antibiotics may 
be chosen in 
select patients
1 2 3 4 6 7
3
V Perforated 
appendix with 
generalized 
peritonitis
Laparoscopic 
appendectomy 
when feasible
1 2 3 4 6 7
Key points
Laparoscopic appendectomy is considered the gold 
standard for acute appendicitis and should be the 
procedure of choice, except when laparoscopy is 
contraindicated or not feasible. Studies have demon-
strated the laparoscopic approach is equivalent to, 
or better than, the open technique in most circum-
stances. Conversion to open may be necessary in 
technically difficult cases, however. Laparoscopic 
appendectomy is safe in the obese, elderly patients, 
pediatric patients and pregnant patient populations, 
including in the third trimester.1, 2, 3, 4, 6, 7
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Non-operative therapy is a reasonable approach in uncomplicated 
acute appendicitis. Patients should be educated that the possibility of 
recurrence exists. Non-operative therapy may also be considered in 
some cases of acute appendicitis with phlegmon or abscess.3 In most 
other situations, appendectomy is the standard of care.
CT imaging is more reliable that ultrasound for the diagnosis of 
acute appendicitis. The use of intravenous contrast may improve 
the sensitivity of this test and is generally recommended when CT 
imaging is performed. Exceptions to CT may be pursued in preg-
nant women and children to minimize exposure to radiation. Ultra-
sound is preferred for diagnosis in pregnant patients and children. 
If ultrasound is equivocal, MRI would be the next diagnostic test of 
choice.2, 3, 5, 8
Preoperative antibiotics should be administered as soon as the 
diagnosis of acute appendicitis is made. There is no indication for 
postoperative antibiotics in uncomplicated appendicitis.2 There are 
also no data supporting improvement in clinical outcomes with any 
given scoring system for acute appendicitis.3
Technical maneuvers, such as peritoneal irrigation, variations 
in appendiceal stump closure or methods of mesenteric vascular 
control have demonstrated no difference in outcomes.3
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ACuTe ChOleCysTiTis mAnAgemenT guidelines 
summAry
Hepaticopancreaticobiliary conditions comprise up to 26% of 
emergency general surgery (EGS) admissions, of which 40% 
require an operation.1 In 2012, acute calculus cholecystitis was the 
second most common gastrointestinal reason for hospital admis-
sion, resulting in over 225 000 hospital admissions.2 Gallstones 
occur in 10%–15% of the adult population, of whom 80% are 
asymptomatic. Acute cholecystitis develops in 1%–3% of patients 
with symptomatic gallstones3 and occurs most frequently in 
patients aged 18–44. There is a predominance in females (86 cases 
per 10 000 discharges in women compared with 65 per 10 000 
discharges in men) and the incidence and hospital costs associated 
with acute cholecystitis appear to be rising.4
There are multiple published guidelines related acute cholecys-
titis focusing on diagnosis, management, and timing of surgical 
therapy. Of these, the most prominent are the Tokyo Guidelines 
(published in 20075 with updates in 20136 and subsequently 
updated in 2018)7 which include a severity grading for acute 
cholecystitis. As with several other common EGS disease states, 
the American Association for the Surgery of Trauma (AAST) has 
developed a grading system for acute cholecystitis that addresses 
clinical, radiologic, operative and pathologic features of acute 
cholecystitis and which has recently been validated in the litera-
ture.8 The recommendations in this review are based on guidelines 
put forth by organizations whose mission includes the advance-
ment of research and clinical care for patients with cholecystitis, 
but the underlying literature supporting these guidelines is heter-
ogenous with respect to inclusion criteria and definitions of expo-
sures and outcomes. Notably, because this literature predates the 
publication of AAST severity grades for acute cholecystitis, the way 
in which these guidelines pertain to specific AAST grades of acute 
cholecystitis requires further investigation.
grade
AAsT disease 
grade
Corres-
ponding 
Tokyo grade management
ref-
erences
I Local disease;
confined to the 
organ;
minimal 
abnormality
I Operative (laparoscopic if 
possible) if within 10 days of 
onset of symptoms; consider 
antibiotics±percutaneous 
cholecystostomy tube if 
beyond 10 days
7 9 10 11
II Local disease;
confined to the 
organ;
severe 
abnormality
II Operative (laparoscopic if 
possible; consideration of 
conversion to open/subtotal 
cholecystectomy as dictated 
by intraoperative findings); 
antibiotics and percutaneous 
cholecystostomy tube may be 
considered, but evidentiary 
support for populations 
who may benefit from this 
approach is sparse
7 9 10–12
III Beyond the 
organ;
locally advanced 
only
II Operative (laparoscopic if 
possible; consideration of 
conversion to open/subtotal 
cholecystectomy as dictated 
by intraoperative findings); 
antibiotics and percutaneous 
cholecystostomy tube may be 
considered, but evidentiary 
support for populations 
who may benefit from this 
approach is sparse
7 9 10–12
IV Beyond the 
organ;
regional 
extension
II Operative (laparoscopic if 
possible; consideration of 
conversion to open/subtotal 
cholecystectomy as dictated 
by intraoperative findings)
7 9 10–12
V Beyond the 
organ;
widespread 
involvement
III Operative (laparoscopic 
if possible; consideration 
of open approach in the 
setting of septic shock; 
strong consideration of 
conversion to open/subtotal 
cholecystectomy as dictated 
by intraoperative findings)
7 9 10–12
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Key pOinTs
Cholecystectomy is the gold standard for treatment of acute 
calculous cholecystitis (ACC).9 Clinical outcomes for surgery 
are superior to observation in ACC and shows some cost-ef-
fectiveness advantages—due to gallstone-related complications 
and high rates of readmission and surgery in the observation 
group.1314
Laparoscopic cholecystectomy is recommended over open 
cholecystectomy in ACC.10 11 15 Among high-risk patients, in 
those with Child A and B cirrhosis,16 advanced age >80,17 or 
pregnant women,18 laparoscopic cholecystectomy for ACC is 
feasible and safe. A laparoscopic approach should initially be 
attempted except in case of absolute anesthesiology contraindi-
cations or septic shock.15
Laparoscopic or open subtotal cholecystectomy is a valid 
option for advanced inflammation, gangrenous gallbladder, or 
any setting of the ‘difficult gallbladder’ where anatomy is diffi-
cult to recognize and main bile duct injuries are more likely.12
Although the definition of early versus late surgery varies by 
study, in general early laparoscopic cholecystectomy is preferable 
to delayed laparoscopic cholecystectomy in patients with ACC as 
long as it is completed within 10 days of onset of symptoms.19 20 
Laparoscopic cholecystectomy should not be offered for patients 
beyond 10 days from the onset of symptoms unless symptoms 
suggestive of worsening peritonitis or sepsis warrant an emer-
gency surgical intervention. In people with more than 10 days of 
symptoms, delaying cholecystectomy for 45 days is better than 
immediate surgery.21
Antibiotics should be suggested as supportive care; they are 
effective in treating the first episode of ACC, but a high rate of 
relapse can be expected. Surgery is more effective than antibiotics 
alone in the treatment of ACC. 19 22 Patients with uncomplicated 
cholecystitis can be treated without postoperative antibiotics 
when the focus of infection is controlled by cholecystectomy.23
Percutaneous cholecystostomy could be considered as a 
possible alternative to surgery after the failure of conserva-
tive treatment in a small subset of patients unfit for emergency 
surgery due to their severe comorbidities.9 There are no reports 
providing quality scientific evidence on the best timing for 
surgery after percutaneous cholecystostomy, so a consensus has 
not been reached.24
AreAs Of OngOing reseArCh
Several guidelines suggest considerations for estimation of 
perioperative risk in ACC, but there is currently no consensus 
as to the most accurate and reliable method of risk stratification. 
Future works should focus on a generalizable and approachable 
method of identifying high-risk patients.
Use of percutaneous cholecystostomy tubes in patients at 
elevated risk for surgery appears to be increasing, but the indica-
tions for this procedure and the optimal management thereafter 
are not well defined. Future investigations should help address 
these knowledge gaps.
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ACuTe COlOniC diverTiCuliTis mAnAgemenT 
guidelines summAry
Acute colonic diverticulitis is the sixth most common gastroin-
testinal diagnosis and represents a significant burden of disease.1 
Between 2000 and 2009, admissions for diverticulitis increased 
41%, representing over 219 000 discharges and US$2.1 billion 
dollars in inpatient charges.2 As the population ages, these 
numbers are likely to increase, since at least 60% of people over 
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the age of 60 have diverticulosis and 10%–25% will progress to 
diverticulitis at some point.2-3 Though 85% of these episodes are 
likely to be uncomplicated, 15%–30% will experience at least 
one recurrence.3
Diverticulitis may occur at any age. Factors associated with 
diverticulitis include a low-fiber diet and a sedentary lifestyle 
leading to obesity.4 The initial episode has the highest associa-
tion with need for surgical therapy, as scarring related to these 
episodes is though to make perforation with subsequent episodes 
less likely.1 Complicated diverticulitis is associated with smoking, 
non-steroidal anti-inflammatory drug use, organ transplantation 
and steroid use.2, 4
The American Association for the Surgery of Trauma (AAST) 
has developed a grading system for diverticulitis that addresses 
clinical, radiologic, operative and pathologic grades of disease. 
This system has been validated in the literature.5 This addresses 
noted gaps of current grading systems, such as those inherent 
in the original Hinchey system or the Ambrosetti CT classifica-
tion.4, 6-8 Recommendations regarding the management of diver-
ticulitis are based on a combination of expert consensus and 
research. Overall, quality of the research is mixed, with many 
studies suffering from small numbers and issues with bias.
grade
AAsT 
disease 
grade
Corres-
ponding
hinchey 
grade management references
I Local 
disease;
confined to 
the organ;
minimal 
abnormality
N/A, O Outpatient care
Selective antibiotics
2 3 4 9 10 11 14
3 4 9 11
II Local 
disease;
confined to 
the organ;
severe 
abnormality
I, I Outpatient care
Selective antibiotics
2 3 4 9 10 11 14
3 4 9 11
III Beyond the 
organ;
locally 
advanced 
only
I, II Antibiotics±percutaneous 
drainage
3 4 9 10 11
IV Beyond the 
organ;
regional 
extension
II, III Antibiotics±percutaneous 
drainage
3 4 9 10 11
V Beyond the 
organ;
widespread 
involvement
III, IV, IV Resection with stoma
Selected single-stage 
operations
3 4 9 11
3 4 7 9 10 11
Key pOinTs
For the management of uncomplicated diverticulitis (grades 1 
and 2), it is safe and reasonable to manage as an outpatient in 
otherwise healthy patients. 2, 3, 4, 9, 10, 11
Routine use of antibiotics is currently the standard of care 
and is successful in 90% of cases of grades 1 and 2 diverticu-
litis. Recent literature has indicated that a more selective use of 
antibiotics, individualized to the patient’s clinical state, is pref-
erable. Antibiotics have not been shown to decrease the severity 
or duration of symptoms and may be associated with allergic 
reaction and resistance. 3, 4, 9, 11
There are no data to support avoiding seeds, nuts or corn, 
or other dietary restrictions as a means to avoid recurrent 
diverticulitis. Data is mixed regarding the role of dietary fiber in 
preventing recurrent disease. Overall, increased vigorous activity 
is supported, though the exact role between activity and recur-
rent diverticulitis is unclear. 4, 9, 10
In grades 3 and 4 diverticulitis, a contained abscess may be 
treated with antibiotics if small, or percutaneous drainage and 
antibiotics if larger, as long as there are no other indications for 
surgery. 3, 4, 9, 10, 11
During the last decade, attempts have been made to treat grade 
3–5 diverticulitis with laparoscopic washout. Multiple trials in 
Europe, including the laparoscopic lavage (LOLA) trial, the Scan-
dinavian Diverticulitis trial and DIVER (Outpatient versus hospi-
talization management for uncomplicated diverticulitis) trial found 
increased need for subsequent operations in patients undergoing 
laparoscopic peritoneal lavage. Laparoscopic lavage is no longer 
supported in the treatment of acute diverticulitis.12, 13
The gold-standard remains exploratory laparotomy with resec-
tion for fecal peritonitis. A two-stage procedure (Hartmann’s) 
is still the most commonly performed surgery in the setting of 
acute inflammation. 3, 4, 9, 11 A growing body of literature supports 
primary anastomosis, with or without a diverting loop ileostomy, 
in carefully selected patients. 3, 4, 7, 9, 10, 11
Evidence regarding the role of colonoscopy screening after acute 
diverticulitis is mixed. In symptomatic patients, screening colo-
noscopy is still recommended. In asymptomatic patients, who are 
compliant with a standard screening schedule, additional colonos-
copy is likely not warranted and low yield.1, 3, 4, 9, 10, 11
Elective colonic resection after the second episode of acute 
colonic diverticulitis is no longer recommended. The decision 
for surgery should be individualized to the patient. Laparo-
scopic approaches are recommended where possible to decrease 
post-operative risk of small bowel obstruction and post-opera-
tive hernia.9, 10
Areas of ongoing research
Immunocompromised patients, including those who have had 
solid organ transplants or who take chronic steroids, are a special 
population. Earlier operative intervention, with a more conserva-
tive staged approach, may be warranted.
Duration of antibiotic therapy is still not standardized. An 
individualized, patient-based approach is still the preferred 
approach.
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inTesTinAl ObsTruCTiOn due TO AdhesiOns guideline 
summAry
Small bowel obstruction (SBO) is a common cause for hospital 
admission and surgical consultation. Although the diagnosis of 
SBO has become relatively straightforward with the use of CT, 
there continues to be a debate as to its optimal management. 
Multiple societies have published guidelines for the diagnosis 
and management of SBO. This review summarizes and refer-
ences evidence-based guidelines for diagnosis, treatment and 
management of SBO. This should be used as a reference guide 
for surgeons practicing emergency general surgery.
grade
AAsT disease 
grade diagnosis management references
I Partial SBO CT scan of 
abdomen and 
pelvis
Water soluble 
contrast follow 
through to rule 
out complete 
adhesive 
small bowel 
obstruction 
(ASBO) and 
predict need for 
surgery
Initial non-operative 
management.
Water-soluble contrast 
follow through to rule 
out complete ASBO and 
predict the need for 
surgery.
Surgery recommended 
after 3 days without 
resolution.
Patients with SBO 
should generally be 
admitted to a surgical 
service
1 2 3 4 5 6
II Complete 
SBO; bowel 
viable and not 
compromised
CT scan of 
abdomen and 
pelvis
Water soluble 
contrast follow 
through to rule 
out complete 
ASBO and 
predict need for 
surgery
Initial non-operative 
management.
Water-soluble contrast 
follow through to rule 
out complete ASBO and 
predict the need for 
surgery.
Surgery recommended 
after 3 days without 
resolution.
Patients with SBO 
should generally be 
admitted to a surgical 
service
1 2 3 4 5 6
III Complete 
SBO with 
compromised 
but viable 
bowel
CT scan of 
abdomen and 
pelvis
Water soluble 
contrast follow 
through to rule 
out complete 
ASBO and 
predict need for 
surgery
Operative management.
Open surgery is 
preferred method.
Laparoscopic approach 
can be attempted in 
select cases.
1 2 3 4 5 6
grade
AAsT disease 
grade diagnosis management references
IV Complete SBO 
with non-
viable bowel 
or perforation 
with localized 
spillage
CT scan of 
abdomen and 
pelvis
Operative management.
Open surgery is 
preferred method.
Laparoscopic approach 
can be attempted in 
select cases.
Patients with SBO 
should generally be 
admitted to a surgical 
service.
1 2 3 4 5 6
V Small bowel 
perforation 
with diffused 
peritoneal 
contamination
CT scan of 
abdomen and 
pelvis
Operative management.
Open surgery is 
preferred method.
Laparoscopic approach 
can be attempted in 
select cases.
Patients with SBO 
should generally be 
admitted to a surgical 
service.
1 2 3 4 5 6
Key pOinTs
Radiographs have relatively limited use for the imaging confir-
mation and characterization of an obstruction. Patients with a 
strong clinical suspicion for ASBO, immediate cross-sectional 
imaging with CT should be considered.1 CT scan has proven 
to be highly diagnostic in ASBO and is the diagnostic test of 
choice.1,2 MRI is ideal for children and pregnant patients with 
known or suspected SBO, as well as younger patients with 
repetitive episodes of obstruction.1 If intermittent, recurrent, or 
low-grade SBO is a primary concern, an enteroclysis is likely the 
next best test.1
Water-Soluble-Contrast-Medium such as Gastrografin is safe 
and has a definite role in diagnosis (for predicting the resolu-
tion or need for surgery) and therapy (for reducing the operative 
rate, shortening time to resolution, hospital stay).1,3-6 The unique 
ability of Gastrografin to draw water into the bowel lumen expe-
dites resolution of partial obstructions. Contrast in the colon on 
abdominal X-ray within 24 hours of its administration predicts 
resolution of ASBO.3-6 If not obtained at admission, water-sol-
uble contrast studies should be considered in patients who do 
not clinically resolve after 48 hours for both diagnostic and 
potential therapeutic purposes.
Patients with evidence of generalized peritonitis or other clin-
ical deterioration (fever, leukocytosis, tachycardia, metabolic 
acidosis, continuous pain) should undergo timely exploration. 
The remainder of patients can safely undergo initial non-opera-
tive management for both partial and complete SBO. The goal is 
to immediately identify strangulation and need for urgent oper-
ative intervention using a combination of clinical signs and CT 
findings. Surgery is recommended after 3 days without resolu-
tion (but less than 5 days).3-5
Laparoscopy is safe and feasible in the hands of experienced 
laparoscopic surgeons and in selected patients.4,5
Patients with SBO admitted to a surgical service have shorter 
length of stay, less hospital charges, shorter time to surgery, and 
lower mortality than patients admitted to a medical service.4
Hyaluronic acid-carboxycellulose membrane and icodextrin 
are proven to reduce adhesions but have not proven to reduce 
the need for surgery.3
AreAs fOr OngOing reseArCh
The role of surgical techniques and biomaterials that can 
prevent ASBO and reduce the need for surgical intervention are 
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topics that warrant further research. Adhesions quantification 
and scoring is a promising tool for further research that could 
help standardization and allow for more accurate analysis of 
ASBO.
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ACuTe pAnCreATiTis mAnAgemenT guidelines 
summAry
Acute pancreatitis is one of the most common diseases of the 
gastrointestinal tract and its incidence may be increasing. It is the 
most common discharge diagnosis for patients hospitalized for a 
gastrointestinal disease.4 Changes in approach to acute pancre-
atitis have occurred during the last two decades. These changes 
were primarily driven by the development of the Atlanta classi-
fication for disease severity and the recognition of the early and 
later phases of disease. The early phase being a period of systemic 
inflammation of variable severity and the later phase being 
marked by local complications.4 There are multiple published 
guidelines related to acute pancreatitis. Most of the guidelines 
focus on the areas of diagnosis, early management, indications 
for endoscopic procedures and indications for surgical proce-
dures. This review highlights the American Association for the 
Surgery of Trauma (AAST) grade specific management recom-
mendations for surgeons engaged in the care of these patients. 
This brief report summarizes guidelines published on the topic 
of acute pancreatitis until May 30, 2017. Only guidelines with 
rigorous, reproducible methodologies were selected for this 
report.
AAsT grade description management references
i Acute edematous 
pancreatitis
Diagnosis by serum markers.
Supportive management and 
enteral nutrition as tolerated. 
Cholecystectomy at index 
admission if gallstones present.
Antibiotics not indicated.
If concomitant cholangitis 
is present early ERCP 
should be performed. For 
choledocholithiasis, without 
cholangitis ERCP can be 
delayed for 72 hours.
1 2 3 4
ii Pancreatic 
phlegmon or 
peripancreatic 
fluid collection or 
hemorrhage
Same as grade I plus CT 
scanning at least 72 hours 
after symptom onset.
1 2 3 4
AAsT grade description management references
iii Sterile pancreatic 
necrosis
Same as grade II disease
Management in a monitored 
setting (intensive care unit)
Parenteral nutrition for those 
failing enteral nutrition.
1 2 3 4
iv Infected pancreatic 
necrosis or abscess
Same as grade III disease.
Antibiotics for suspected 
infection.
Consider percutaneous 
sampling or drainage
Necrosectomy delayed at least 
14 days after symptom onset
Necrosectomy technique 
guided by local expertise.
Open necrosectomy should be 
avoided
1 2 3 4 5
v Extrapancreatic 
extension of 
pancreatic necrosis 
involving adjacent 
organs, such as 
colonic necrosis
Same as grade IV disease. 1 2 3 4 5
Key pOinTs
There is a lack of well-done clinical trials in acute pancreatitis 
that has led to variability in practice within institutions, between 
institutions and across continents. Therefore, recommendations 
must be tailored to the clinical situation and the patient being 
treated and do not represent a standard of care.
The diagnosis of pancreatitis is made when amylase and lipase 
elevations reach three times the upper limit of normal without 
renal failure. Abdominal ultrasound should always be obtained to 
assess for the presence of gallstones and the size of the common 
bile duct. However, confirmatory CT imaging should be reserved 
for more severe disease and should be performed after at least 
72 hours of symptoms.1 Magnetic resonance cholangiopancrea-
tography (MRCP) or endoscopic ultrasound (EUS) are only 
indicated if the common bile duct is dilated, liver enzymes are 
elevated in an obstructive pattern or common bile duct stones 
are highly suspected for another reason.2,4 If the patient is over 
40, neoplastic causes should also be considered.
Supportive care including aggressive fluid resuscitation, 
correction of electrolytes and pain control should be provided. 
Aggressive fluid resuscitation should be with lactated ringers 
and occur during the first 12–24 hours in patients who have 
no contraindications to significant fluid loading.2,4 In the event 
of concomitant cholangitis, urgent (within 24 hours) endo-
scopic retrograde cholangipancreatography (ERCP) should be 
performed. ERCP should also be performed if common bile duct 
obstruction without cholangitis is suspected; however, in this 
case, it can be delayed up to 72 hours.1 If ERCP is performed, 
pancreatic duct stents or postprocedural rectal non-steroidal 
anti-inflammatories should be used in patients at high risk for 
postprocedural pancreatitis.4 The ongoing severity of disease 
should be assessed with daily C-reactive protein and Acute Phys-
iology and Chronic Health Evaluation-II score for the first 72 
hours.2
Optimal nutritional management and antibiotic treatment in 
acute pancreatitis remains somewhat controversial. In lower 
grades of pancreatitis, patients should take a diet as tolerated. 
If patients are intolerant of oral feeding, a nasojejunal tube is 
preferred over parenteral nutrition provided tube feeding can 
be tolerated.2,3 Recommendations for antibiotics in pancre-
atitis have varied over time. Currently, antibiotics are only 
7Schuster KM, et al. Trauma Surg Acute Care Open 2019;4:e000281. doi:10.1136/tsaco-2018-000281
Open access
recommended in the case of strongly suspected infection. Anti-
biotics that penetrate the pancreatic parenchyma should be used 
in cases of infected pancreatic necrosis.
Peripancreatic fluid collections management is based mostly on 
large retrospective studies. The main indication for intervention 
in pancreatic necrosis is infected pancreatic necrosis and clin-
ical deterioration. However, sampling of fluid or necrosis should 
only be performed if infection is strongly suspected.2 Interven-
tion may also be indicated for persistent symptoms with sterile 
necrosis that has been present for at least 8 weeks. A step-up 
approach with initial image guided or endoscopic drainage 
should be used for infected pancreatic necrosis.2 Surgical inter-
vention in these cases should be delayed as long as possible and 
ideally for at least 4 weeks after onset of symptoms to allow 
the collection to become walled off.3 Pseudocysts should only be 
drained if symptomatic or enlarging2.
Cholecystectomy on the index admission is indicated in mild 
gallstone pancreatitis when symptoms resolve. In patients with 
peripancreatic fluid collections, cholecystectomy should be 
delayed until resolution or 6 weeks, whichever is first.5 If chole-
cystectomy is contraindicated, sphicterotomy should be consid-
ered.5 In the case of multiple episodes of pancreatitis without a 
clear etiology, additional imaging including EUS or secretin-stim-
ulated MRCP should be performed.3
Areas of ongoing research
Theare are many controversies that remain with respect to acute 
pancreatitis from presentation to long-term follow-up. Although 
criteria to diagnose acute pancreatitis and assign a severity on 
presentation are firmly established, prediction of disease severity 
during the subsequent days has met with only limited success. 
Additional research in this area is important as the progress of 
disease is highly variable and predicting disease severity will 
allow for more directed use of resources.
Despite strong agreement on the need to delay CT scanning 
for acute pancreatitis until 72–96 hours after the onset of symp-
toms, there is only low-quality evidence supporting this prac-
tice. There is widespread use of MRCP and EUS; however, 
the evidence for their use is also minimal. Studies that more 
firmly establish the role and timing of imaging in pancreatitis 
are essential. Current therapeutic interventions in acute pancre-
atitis are also poorly supported. There is, however, reason-
ably good evidence for withholding intravenous antibiotics to 
prevent infectious complications of acute pancreatitis. Selective 
gut decontamination and probiotic administration also remain 
controversial but may have a role if future studies demonstrate 
value. Despite strong agreement that enteral nutrition is superior 
to parenteral nutrition and that nasogastric feeding is equivalent 
to nasojejunal feeding, there is less agreement for the timing of 
feeding patients with acute pancreatitis and the type of feeding. 
Additionally, despite the strong agreement, the evidence for the 
superiority of enteral feeding is lacking.
Several uncertainties in the procedural management of acute 
pancreatitis also exist. Although there are relatively well-es-
tablished indications for ERCP, the timing of ERCP in patients 
with concomitant pancreatitis and common bile duct obstruc-
tion and/or cholangitis has not been firmly established. There 
is likely benefit to early performance of ERCP when cholangitis 
is present, however, how early is unclear. There are insufficient 
data to make a recommendation regarding the method and 
exact timing of pancreatic necrosectomy for infected pancreatic 
necrosis. Similarly, there are insufficient data to recommend an 
initial procedure for draining infected pancreatic necrosis.
Other uncertainties also require further clarification. There is 
insufficient evidence to make recommendations regarding the 
evaluation of multiple episodes of idiopathic pancreatitis. Espe-
cially, as this pertains to cholecystectomy. There are insufficient 
data to recommend strongly for or against endoscopic sphincter-
otomy in patients with pancreatitis and gallstones and who are 
poor surgical candidates. Outcomes of acute pancreatitis have 
not improved significantly during the last decade; however, stan-
dardizing care by answering these important questions has the 
greatest immediate potential to improve outcomes.
RefeRences
 1. American Gastroenterological Association (AGA) Institute on "Management of 
Acute Pancreatits" Clinical Practice and Economics Committee. AGA Institute 
governing board. AGA Institute medical position statement on acute pancreatitis. 
Gastroenterology 2007:2019–-21.
 2. Greenberg JA, Hsu J, Bawazeer M, Marshall J, Friedrich JO, Nathens A, Coburn N, 
May GR, Pearsall E, McLeod RS. Clinical practice guideline: management of acute 
pancreatitis. Can J Surg 2016;59:128–40.
 3. Working Group IAP/APA Acute Pancreatitis Guidelines. IAP/APA evidence-based 
guidelines for the management of acute pancreatitis. Pancreatology 2013;13(4 Suppl 
2):e1–15.
 4. Tenner S, Baillie J, DeWitt J, Vege SS. American College of gastroenterology guideline: 
management of acute pancreatitis. Am J Gastroenterol 2013;108:1400–15.
 5. Uhl W, Warshaw A, Imrie C, Bassi C, McKay CJ, Lankisch PG, Carter R, Magno ED, 
Banks PA, Whitcomb DC, et al. IAP guidelines for the surgical management of acute 
pancreatitis. Pancreatology 2002;2:565–73.
